A global shortage of ADHD medications is forcing doctors to get creative and pushing pharmacists into a "Hunger Games" style ...

One million Australians could be forced to fork out more for medicines used to treat ADHD as widespread shortages could last ...

With Teva entering the next stage of its sweeping restructuring plan, thousands of employees are slated to be let go from the hybrid generics and innovative medicines giant. As part of a new bid ...

We recently published a list of Why These 10 Stocks Soared Today. In this article, we are going to take a look at where Teva Pharmaceutical Industries Limited (NYSE:TEVA) stands against other ...

Operating Margin Target: 30% by 2027. Net Savings Target: $700 million by 2027. Teva Pharmaceutical Industries Ltd (NYSE:TEVA) reported its ninth consecutive quarter of growth, with revenue up 5% ...

Q1 adjusted EPS was $0.52, beating $0.48 estimates; Teva raised 2025 EPS outlook to $2.45–$2.65. Don’t miss this list of 3 high-yield stocks—including one delivering over 10%—built for ...

JERUSALEM (Reuters) - Teva Pharmaceutical Industries reported a larger than expected rise in first-quarter profit, helped by strong sales gains for a trio of its branded drugs treating migraines ...

Shares of Teva Pharmaceutical (NYSE:TEVA) traded higher in the premarket on Wednesday after the generic drugmaker cited unfavorable forex movements as its revenue for the first quarter of 2025 ...